AGER and chronic obstructive pulmonary disease: We found that lower plasma sRAGE levels were significantly associated with the presence of COPD, the AGER polymorphism rs2070600, the severity of airflow obstruction, the severity of emphysema on HRCT, heterogeneous distribution of emphysema, the centrilobular subtype of emphysema, and 5-year progression of emphysema severity.